i-SENS Inc
099190.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$603.88B
Close$
$-5276.31
125.1% downside
Current Fair Value
125.1% downsideOvervalued by 125.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $603.88 Billion |
|---|---|
| Enterprise Value | $726.20 Billion |
| Dividend Yield | $100.00 (0.60%) |
| Earnings per Share | $-186.24 |
| Beta | 0.43 |
| Outstanding Shares | 26,635,000 |
Return
| Return on Equity | -0.96% |
|---|---|
| Return on Assets | -0.54% |
| Return on Invested Capital | -0.42% |
Valuation & Multiples
| P/E Ratio | -157.95 |
|---|---|
| PEG | -52.74 |
| Price to Sales | 1.72 |
| Price to Book Ratio | 1.57 |
| Enterprise Value to Revenue | 2.23 |
| Enterprise Value to EBIT | -390 |
| Enterprise Value to Net Income | -228 |
| Total Debt to Enterprise | 0.23 |
| Debt to Equity | 0.51 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 27, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$80.40 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About i-SENS, Inc.
687 employees
CEO: Geun-Sig Cha Based in South Korea, i-SENS, Inc. specializes in the provision of diagnostic biosensor technology. Its product portfolio encompasses a range of point-of-care (POC) testing equipment, including analyzers for HbA1c, blood gas, electrolyte...